Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
16 participants
INTERVENTIONAL
1994-11-30
1996-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reinforcing Effects of Brief Exposures to Nitrous Oxide - 8
NCT00000256
Lack of Acute Tolerance Development to Effects of Nitrous Oxide - 4
NCT00000252
Differential Acute Tolerance Development to Effects of Nitrous Oxide - 7
NCT00000255
Role of Instructions in Nitrous Oxide Effects and Choice - 10
NCT00000258
Network-Level Effects of Nitrous Oxide in the Human Brain
NCT03435055
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo + 10% N2O
0% N2O inhaled during psychomotor testing, 10% N2O inhaled during psycho motor testing, then subject's choice of the 2.
10% N2O
Placebo + 20% N2O
Placebo inhaled during psychomotor testing, 20% N2O inhaled during psychomotor testing, then subject's choice of the 2.
20% N2O
Placebo + 30% N2O
Placebo inhaled during psychomotor testing, 30% N2O inhaled during psychomotor testing, then subject's choice of the 2.
30% N2O
Placebo + 40% N2O
Placebo inhaled during psychomotor testing, 40% N2O inhaled during psychomotor testing, then subject's choice of the 2.
40% N2O
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
10% N2O
20% N2O
30% N2O
40% N2O
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
21 Years
37 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
University of Chicago
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James Zacny, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Chicago
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Chicago, Anesthesia & Critical Care
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Behavioral Pharmacology, 1996, 7: 194-199.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R01-08391-5
Identifier Type: -
Identifier Source: secondary_id
NIDA-08391-5
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.